Semax 5mg
Semax is a synthetic heptapeptide analog of ACTH(4-10) developed at the Institute of Molecular Genetics in Russia. It is approved in Russia as a nootropic and neuroprotective agent. Research demonstrates BDNF/NGF upregulation, cognitive enhancement, neuroprotection against ischemia, and attention improvement without hormonal effects of full ACTH.
Sequence
Met-Glu-His-Phe-Pro-Gly-Pro
Market avg: $44.99 — save 38%
Volume pricing
Pay with USDC via Coinbase Commerce
Certificate of Analysis
Independently verified by Janoshik Analytical
Test ID
JAN-SMX-2026-001
Purity
99.2%
Method
HPLC-MS
Batch
SMX-2026-01A
Test Date
February 1, 2026
Identity
Confirmed
Storage Requirements
Lyophilized
Room temperature (15-25°C), protect from light
Reconstituted
2-8°C, use within 21 days
ACTH(4-7) analog. Very stable heptapeptide.
Published Research
2 peer-reviewed studies
Semax, an ACTH(4-10) analog with nootropic properties, activates expression of neurotrophins and their receptors in rat hippocampus
Dolotov OV, Karpenko EA, Inozemtseva LS, et al. — Regulatory Peptides, 2006
Study demonstrating Semax upregulation of BDNF and NGF in hippocampal tissue.
Semax modulates the turnover of serotonin and dopamine in the brain of rats
Eremin KO, Kudrin VS, Saransaari P, et al. — Doklady Biological Sciences, 2005
Evidence for Semax modulation of monoamine neurotransmitter systems.
Related Products
Research use only. All products are sold strictly for in-vitro research purposes only. Not for human consumption. Information provided references published research literature. No medical claims are made or implied.